MiNK Therapeutics
INKT
NASDAQ
IPO2021
about INKT
MiNK Therapeutics is a biotechnology company focused on developing innovative antibody-based cancer treatments targeting solid tumors.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $15.71 | $16.93 | $12.70 | $49.05M | 15.03M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.65 | n/a | 1127.89 | -5772.50% | -5236.00% | 0% |